DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



A Comparison of the Pain Relief From Dysmenorrhea Between Ibuprofen or the Vipon Tampon

Information source: Truman Medical Center
Information obtained from ClinicalTrials.gov on August 08, 2008
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Dysmenorrhea

Intervention: Vipon (Device); Ibuprofen (Drug)

Phase: N/A

Status: Recruiting

Sponsored by: Truman Medical Center

Official(s) and/or principal investigator(s):
Julie L. Strickland, M.D., Principal Investigator, Affiliation: Truman Medical Center

Overall contact:
Jacki Witt, WHNP, RN, Phone: 816-404-5173, Email: jacki.witt@tmcmed.org

Summary

To compare pain relief in symptom clusters (abdominal pain, back pain, cramps) between Vipon and ibuprofen.

Clinical Details

Official title: A Randomized Four-Way Crossover Comparison Study of Pain Relief From Dysmenorrhea Between the Vipon Tampon and Ibuprofen.

Study design: Treatment, Randomized, Open Label, Active Control, Crossover Assignment, Safety/Efficacy Study

Primary outcome: The primary outcome for the study is pain relief.

Secondary outcome: Quality of Life between the Vipon and ibuprofen, safety evaluation of the Vipon tampon, and time of pain relief between the Vipon and ibuprofen.

Detailed description: To compare Quality of Life between treatment with Vipon and ibuprofen. To compare time of pain relief between Vipon tampon and ibuprofen. To assess the safety of the Vipon tampon.

Eligibility

Minimum age: 18 Years. Maximum age: N/A. Gender(s): Female.

Criteria:

Inclusion Criteria:

- Must have four (4) consecutive monthly menstrual cycles

- Self-assessment of dysmenorrhea

- Non-pregnant

- Adequate birth control during trial

- Consent to use tampons through all assessments

- Able to use ibuprofen

Exclusion Criteria:

- Prohibited use of pain medications 4 hours prior to treatment and during the first 2

hours after treatment with study medication (ibuprofen).

- Positive pregnancy test

- Unwilling or unable to comply with the study protocol

- Allergic to ibuprofen

Locations and Contacts

Jacki Witt, WHNP, RN, Phone: 816-404-5173, Email: jacki.witt@tmcmed.org

Truman Medical Center, Kansas City, Missouri 64108, United States; Recruiting
Julie L. Strickland, M.D., Principal Investigator
Additional Information

Truman Medical Center

University of Missouri-Kansas City

Starting date: March 2006
Ending date: December 2008
Last updated: February 7, 2008

Page last updated: August 08, 2008

-- advertisement -- The American Red Cross
We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2009